V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250011077 | 250008273 | null | null | Disease modification (D) | null | 2017-03-13 | GemCarbo Days 1+8 | N | N | 250024343 | GEMCARBO |
| 250011078 | 250008273 | 1.6 | 83.4 | Curative (C) | 2018-09-28 | 2018-09-28 | R GCVP | 2 | N | 250024343 | GEMCARBO |
| 250011079 | 250011099 | 1.44 | 83 | Disease modification (D) | 2014-10-30 | 2014-11-07 | Capecitabine | 02 | N | 250026128 | CISPLATIN + VINORELBINE |
| 250011080 | 250012204 | 1.53 | 49.2 | Neo-adjuvant (N) | 2014-02-27 | 2014-07-20 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | N | 250026985 | GEMCARBO |
| 250011081 | 250012204 | 1.78 | null | Palliative (P) | 2016-10-01 | 2016-10-23 | Bevacizumab | 2 | N | 250026985 | AML17 TRIAL |
| 250011082 | 250008277 | 1.86 | 71 | Curative (C) | 2015-10-31 | 2015-11-30 | GemCarbo Days 1+8 | Y | N | 250027278 | CARBOPLATIN + PACLITAXEL |
| 250011083 | 250008278 | 1.58 | null | Curative (C) | null | 2019-01-17 | GEMCARBO | null | N | 250027278 | CISPLATIN + PACLITAXEL |
| 250011084 | 250008279 | 1.72 | 62.4 | Neo-adjuvant (N) | 2019-01-31 | 2019-02-12 | GemCarbo Days 1+8 | N | N | 250027713 | CARBOPLATIN |
| 250011085 | 250008279 | 1.78 | 74 | Palliative (P) | 2014-08-05 | 2014-08-23 | Cisplatin + Paclitaxel | 02 | N | 250027713 | CYTARABINE |
| 250011086 | 250008281 | 1.61 | 69.7 | Palliative (P) | 2016-05-16 | 2016-05-16 | Azacitidine | null | N | 250028595 | GEMCARBO |
| 250011087 | 250008283 | 1.64 | 73.8 | Disease modification (D) | 2015-03-10 | 2015-04-07 | BUSULFAN | N | N | 250029279 | TCX |
| 250011088 | 250008285 | null | null | Palliative (P) | 2016-09-12 | 2016-12-05 | GemCarbo Days 1+8 | N | N | 250029468 | AML19 TRIAL |
| 250011089 | 250008286 | 1.78 | 63.6 | Palliative (P) | 2014-02-19 | 2014-02-28 | Cisplatin + Paclitaxel | null | N | 250029468 | CARBOPLATIN |
| 250011090 | 250008287 | 1.68 | 71 | Palliative (P) | null | 2016-09-08 | DA | N | N | 250030629 | IPM |
| 250011091 | 250008288 | null | 78 | Palliative (P) | 2019-05-13 | 2019-08-05 | ATG + Busulfan + Fludarabine | N | null | 250031141 | CARBOPLATIN + PACLITAXEL |
| 250011092 | 250008289 | 1.52 | null | Disease modification (D) | 2016-01-30 | 2017-09-28 | CVP R | N | N | 250031215 | CARBOPLATIN |
| 250011093 | 250008290 | 1.75 | 96 | Palliative (P) | 2016-05-22 | 2016-06-07 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 250031481 | ERIBULIN |
| 250011094 | 250008291 | 1.82 | 91.2 | Palliative (P) | 2013-04-30 | 2015-05-22 | Busulfan Oral | N | N | 250031884 | CISPLATIN + VINORELBINE |
| 250011095 | 250008292 | 1.7 | 100 | Palliative (P) | 2016-05-22 | 2016-06-05 | GemCarbo Days 1+8 | N | N | 250032031 | AZACITIDINE |
| 250011096 | 250008293 | 1.59 | 0 | Palliative (P) | 2017-05-28 | 2017-05-28 | Rituximab | N | N | 250000015 | IPM |
| 250011097 | 250008294 | 1.61 | 80 | Palliative (P) | 2016-09-26 | 2016-11-06 | Cytarabine Low Dose | 02 | null | 250000545 | GEMCARBO |
| 250011098 | 250008295 | null | 0 | Palliative (P) | null | 2016-07-18 | Nilotinib | N | N | 250001228 | CISPLATIN + VINORELBINE |
| 250011099 | 250008296 | null | 0 | Palliative (P) | 2019-02-13 | 2019-02-13 | IMATINIB | 02 | N | 250004070 | CISPLATIN + FLUOROURACIL |
| 250011100 | 250011106 | 1.78 | 75 | Palliative (P) | 2016-08-11 | 2016-09-22 | COMMAND trial | N | N | 250005783 | IPM |
| 250011101 | 250008300 | 0 | 79.4 | Palliative (P) | 2016-08-31 | 2016-08-31 | COMMAND trial | 2 | N | 250006621 | GEMCARBO |
| 250011102 | 250012208 | null | 77 | Palliative (P) | 2019-03-29 | 2019-05-02 | Temozolomide 200mg/m2 | 1 | N | 250008904 | MITOXANTRONE |
| 250011103 | 250012208 | 1.74 | null | Palliative (P) | 2017-10-02 | 2017-10-22 | Azacitidine | N | null | 250008904 | LENALIDOMIDE |
| 250011104 | 250012208 | 1.68 | 88 | Palliative (P) | 2018-12-03 | 2018-12-03 | Enzalutamide | 02 | N | 250008904 | IPM |
| 250011105 | 250008301 | 1.7 | 88.4 | null | 2018-10-26 | 2018-10-27 | PAD | N | N | 250013748 | GEMCARBO |
| 250011106 | 250011109 | 1.68 | null | Disease modification (D) | null | 2015-09-27 | Carboplatin AUC 6 - 10 | 01 | null | 250016994 | BORTEZOMIB |
| 250011107 | 250008302 | 1.68 | 84 | Palliative (P) | 2014-08-16 | 2014-08-16 | CVP R | N | N | 250018170 | AML19 TRIAL |
| 250011108 | 250008305 | 1.68 | 60.9 | Curative (C) | 2018-08-06 | 2018-08-21 | Azacitidine | N | N | 250019740 | NOT MATCHED |
| 250011109 | 250008306 | 1.64 | null | null | null | 2018-10-05 | Cytarabine Low Dose | 99 | N | 250021765 | GEMCARBO |
| 250011110 | 250008307 | 1.66 | 71.1 | Palliative (P) | 2017-11-05 | 2018-05-27 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 250022310 | PEMETREXED |
| 250011111 | 250008307 | null | null | Palliative (P) | 2018-02-06 | 2018-02-20 | CYTARABINE + DAUNORUBICIN | 99 | Y | 250022310 | FLAG + IDARUBICIN |
| 250011112 | 250005677 | 1.76 | 0 | Disease modification (D) | 2014-02-17 | 2014-02-17 | Hydroxycarbamide | N | N | 250000026 | HYDROXYCARBAMIDE |
| 250011113 | 250009968 | null | null | Disease modification (D) | 2016-05-27 | 2016-05-27 | Hydroxycarbamide | 2 | N | 250000038 | HYDROXYCARBAMIDE |
| 250011114 | 250005681 | null | 67.9 | Palliative (P) | 2016-01-27 | 2016-02-25 | Hydroxycarbamide | 02 | N | 250000096 | HYDROXYCARBAMIDE |
| 250011115 | 250005683 | null | null | Curative (C) | 2014-08-18 | 2018-10-07 | Hydroxycarbamide | 02 | N | 250000128 | HYDROXYCARBAMIDE |
| 250011116 | 250005685 | 0 | null | Disease modification (D) | 2018-09-01 | 2018-12-09 | Hydroxycarbamide | null | null | 250000136 | HYDROXYCARBAMIDE |
| 250011117 | 250005686 | 0 | 0 | Adjuvant (A) | 2017-01-30 | 2017-01-30 | Hydroxycarbamide | N | N | 250000140 | HYDROXYCARBAMIDE |
| 250011118 | 250005687 | null | null | Palliative (P) | 2014-10-18 | 2014-10-18 | Hydroxycarbamide | 02 | N | 250000172 | HYDROXYCARBAMIDE |
| 250011119 | 250005691 | null | 0 | Disease modification (D) | 2015-07-01 | 2015-10-14 | Hydroxycarbamide | null | N | 250000213 | HYDROXYCARBAMIDE |
| 250011120 | 250005696 | 0 | 0 | Disease modification (D) | 2017-09-21 | 2017-10-23 | Hydroxycarbamide | N | N | 250000300 | HYDROXYCARBAMIDE |
| 250011122 | 250005703 | null | null | Disease modification (D) | 2017-04-14 | 2017-04-14 | Hydroxycarbamide | null | N | 250000508 | HYDROXYCARBAMIDE |
| 250011123 | 250005706 | null | null | Disease modification (D) | 2016-06-25 | 2016-06-30 | Hydroxycarbamide | N | null | 250000546 | HYDROXYCARBAMIDE |
| 250011124 | 250012436 | 1.85 | 0 | Disease modification (D) | 2018-09-04 | 2018-09-04 | Hydroxycarbamide | N | N | 250000547 | HYDROXYCARBAMIDE |
| 250011125 | 250005708 | 1.63 | 0 | Disease modification (D) | 2018-04-26 | 2018-04-29 | Hydroxycarbamide | N | N | 250000593 | HYDROXYCARBAMIDE |
| 250011126 | 250005709 | 0 | null | Palliative (P) | null | 2019-03-26 | Hydroxycarbamide | N | N | 250000600 | HYDROXYCARBAMIDE |
| 250011127 | 250005713 | null | 0 | Disease modification (D) | 2017-03-19 | 2017-03-20 | Hydroxycarbamide | 02 | N | 250000641 | HYDROXYCARBAMIDE |